Gene Vector Market Size & Share Analysis - Growth, Trends, and Forecasts (2024 - 2029)

The Gene Vector Market Report is Segmented by Vector Type (Lentivirus, Adenovirus, Adeno-Associated Virus (AAV), Plasmid DNA, and Others), Disease (Cancer, Genetic Disorders, Infectious Disease, and Others), Application (Gene Therapy, Vaccinology, and Others), End User (CDMO, CRO, Scientific Research, and Others), and Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Report Offers the Value (USD) for all the Above Segments.

Gene Vector Market Size & Share Analysis - Growth, Trends, and Forecasts (2024 - 2029)

Gene Vector Industry Overview

The gene vector market is moderately fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold significant market share and are well known, including Cell Therapy Catapult Ltd, Charles River Laboratories International Inc., Fujifilm Diosynth Biotechnologies, Genezen Laboratories Inc., Kaneka Eurogentec SA, Lonza Group Ltd, Merck KGaA, Oxford Biomedica PLC, Spark Therapeutics Inc., and uniQure biopharma BV.

Gene Vector Market Leaders

  1. Charles River Laboratories International Inc

  2. Fujifilm Diosynth Biotechnologies

  3. Kaneka Eurogentec SA

  4. Merck KGaA

  5. uniQure biopharma BV

  6. *Disclaimer: Major Players sorted in no particular order
Gene Vector Market Concentration